Topic Hub
24 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 24 of 24 clinical reviews.
A physician-reviewed, evidence-based comparison of compounded semaglutide and branded Ozempic, covering efficacy, safety, regulatory status, cost, and how to choose between them.
Read clinical reviewA physician-reviewed guide to using Ozempic (semaglutide 0.5 to 2.0 mg) after bariatric surgery, covering indications, dosing, pharmacokinetics, safety, and what the evidence actually shows.
Read clinical reviewA comprehensive clinical guide to semaglutide 0.5 to 2.0 mg (Ozempic) use in patients with autoimmune disease, covering immune modulation, disease-specific risks, dosing considerations, and monitoring protocols.
Read clinical reviewA clinical review of semaglutide's effects on cognition, memory, and neuroinflammation, covering trial data, proposed mechanisms, and what patients on Ozempic 0.5 to 2.0 mg should know.
Read clinical reviewA deep review of how semaglutide 0.5 to 2.0 mg (Ozempic) affects sexual function in men and women with type 2 diabetes and obesity, covering trial data, proposed mechanisms, and clinical guidance.
Read clinical reviewA clinical deep-dive into how Ozempic (semaglutide 0.5 to 2.0 mg) reduces appetite and changes food cravings, with primary-literature citations, dose-by-dose data, and practical guidance for patients and prescribers.
Read clinical reviewA physician-level review of every cancer signal linked to semaglutide 0.5 to 2.0 mg (Ozempic), covering thyroid, pancreatic, colorectal, and other malignancy data from SUSTAIN trials, FDA labeling, pharmacovigilance databases, and emerging 2024 cohort studies.
Read clinical reviewA physician-reviewed deep dive into semaglutide 0.5 to 2.0 mg and its long-term cardiovascular effects, covering SUSTAIN-6, SELECT, mechanism data, and practical clinical guidance for type 2 diabetes management.
Read clinical reviewA GRADE-level appraisal of every major semaglutide 0.5 to 2.0 mg trial, from SUSTAIN-1 through SELECT, with certainty ratings, effect sizes, and clinical decision guidance for prescribers and patients.
Read clinical reviewA physician-reviewed guide to semaglutide-related hair loss, skin laxity, and dermatologic side effects, with primary literature citations and clinical management strategies.
Read clinical reviewA clinician-level review of how semaglutide 0.5 to 2.0 mg affects liver enzymes, hepatic fat, MASLD/MASH, and safety monitoring in type 2 diabetes and weight management.
Read clinical reviewA physician-reviewed analysis of how semaglutide 0.5 to 2.0 mg affects mood, anxiety, depression, and neuropsychiatric risk, with citations from primary clinical trials and FDA communications.
Read clinical reviewA physician-reviewed deep dive into how semaglutide 0.5 to 2.0 mg (Ozempic) changes metabolism, resting energy expenditure, fat oxidation, and thermogenesis in type 2 diabetes and off-label weight-loss use.
Read clinical reviewA clinical review of semaglutide microdosing protocols, including off-label sub-threshold dosing rationale, tolerability data, and what current guidelines say about dose titration for Ozempic 0.5 to 2.0 mg.
Read clinical reviewEvidence-based strategies to preserve lean mass while using Ozempic (semaglutide 0.5-2.0 mg) for type 2 diabetes or weight loss, including protein targets, resistance training protocols, and monitoring benchmarks.
Read clinical reviewWhy weight loss stalls on Ozempic (semaglutide 0.5 to 2.0 mg), what the clinical evidence says about dose optimization, and the step-by-step protocol HealthRX clinicians use to break a plateau or identify true non-response.
Read clinical reviewA physician-reviewed guide to the Ozempic pre-surgery hold window, covering ASA and ESAIC guidelines, aspiration risk, GI motility data, and a practical dosing timeline for patients on semaglutide 0.5 to 2.0 mg.
Read clinical reviewA physician-reviewed breakdown of what happens to blood sugar, weight, and metabolic markers when you stop Ozempic (semaglutide 0.5 to 2.0 mg), with primary-trial data, clinical timelines, and guidance on how to stop safely.
Read clinical reviewA clinical deep-dive into semaglutide 0.5 to 2.0 mg and kidney outcomes: FLOW, SUSTAIN-7, LEADER-extension data, GFR trajectories, dosing in CKD, and when Ozempic genuinely protects versus when caution applies.
Read clinical reviewHow heat, cold, travel, illness, and seasonal eating patterns affect Ozempic (semaglutide 0.5 to 2.0 mg) dosing, storage, and glycemic outcomes, with primary-literature citations and clinical decision frameworks.
Read clinical reviewA clinician-level review of how semaglutide 0.5 to 2.0 mg (Ozempic) affects sleep architecture, slow-wave sleep, REM patterns, OSA severity, and circadian signaling, with primary-literature citations throughout.
Read clinical reviewMD/PharmD-level guidance on managing Ozempic (semaglutide 0.5 to 2.0 mg) dosing windows, cold-chain storage, and nausea risk when crossing time zones. Includes a decision framework for shift direction, missed-dose rules, and airport security tips.
Read clinical reviewA week-by-week clinical guide to your first 4 weeks on Ozempic (semaglutide 0.5 mg). Covers blood sugar changes, side effects, appetite shifts, and what your prescriber is watching for.
Read clinical reviewEvidence-based guidance on how to safely restart semaglutide (Ozempic 0.5 to 2.0 mg) after an acute illness interruption, including dose titration, timing, monitoring, and red flags.
Read clinical review